Your browser doesn't support javascript.
loading
Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.
Tonacci, Alessandro; Billeci, Lucia; Pioggia, Giovanni; Navarra, Michele; Gangemi, Sebastiano.
Afiliação
  • Tonacci A; Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), Pisa, Italy.
  • Billeci L; Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), Pisa, Italy.
  • Pioggia G; Institute of Applied Sciences and Intelligent Systems "Eduardo Caianiello" (ISASI), National Research Council of Italy (CNR), Messina, Italy.
  • Navarra M; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
  • Gangemi S; Institute of Applied Sciences and Intelligent Systems "Eduardo Caianiello" (ISASI), National Research Council of Italy (CNR), Messina, Italy.
Pharmacotherapy ; 37(4): 464-480, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28226418

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Omalizumab Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Omalizumab Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article